Multisystem inflammatory syndrome in children (MIS-C and COVID-19)

Dr Tedros Adhanom Ghebreyesus: “Over the weekend, WHO released an update about cases of acute hepatitis of unknown origin among children. So far, at least 169 cases of acute hepatitis have been reported from 11 countries in Europe, and in the United States, in children aged from one month to 16 years. Seventeen children, about 10% of the reported cases have required liver transplants and one death has been reported....” source



Severe hepatitis of 'unknown origin' in children being investigated in Canada
26 April 2022


WS Thread: Acute Hepatitis of Unknown Origin Among Children - 21 April 2022
 
The emergence of Multisystem Inflammatory Syndrome in Children (MIS-C) as a complication of COVID-19 has raised serious concerns worldwide. It highlights how COVID-19 affects more than just the respiratory system, especially in young patients. Understanding how different systems in the body react and how care coordination is managed becomes even more critical. Interestingly, when considering systems in healthcare and other industries, the difference between erp and mis plays a crucial role in ensuring efficient operations and data flow. In the medical context, this can relate to how hospital information systems manage patient data, treatment protocols, and resource allocation. As we learn more about MIS-C, such systemic insights help improve both clinical and administrative responses.
 

Staff online

Members online

Online statistics

Members online
162
Guests online
580
Total visitors
742

Forum statistics

Threads
625,625
Messages
18,507,143
Members
240,826
Latest member
rhannie88
Back
Top